{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:40:29Z","timestamp":1776980429605,"version":"3.51.4"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Short bowel syndrome (SBS) resulting from acute aortic dissection (AAD)-induced visceral malperfusions leads to chronic intestinal failure (CIF), necessitating patients to adopt home parenteral nutrition to prevent malabsorption. Teduglutide (TED), a glucagon-like peptide-2 analog, is a promising pharmacotherapy for intestinal rehabilitation that reduces parenteral support and improves the quality of life. Gastric mucosal necrosis, a rare gastrointestinal disorder, had never been observed as an adverse event relevant to this drug. We report a case of mucosal necrosis in the stomach after TED treatment for SBS-CIF with hepatorenal failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Presentation of case:<\/jats:title>\n                    <jats:p>A 68-year-old Japanese man who underwent massive intestinal resection for AAD experienced malnutrition and diarrhea caused by SBS-CIF. The patient received TED to improve intestinal absorption and entero-hepatic circulation besides controlling infectious diseases. Endoscopy showed mucosal hyperplasia in the stomach and duodenum 1.5 months after TED administration. The patient consented to enteral nutrition via a nasogastric tube because of anorexia. The nutritional status gradually improved after initiating enteral feeding. However, the patient experienced hematemesis 13 days after enteral feeding, and endoscopy revealed acute gastric mucosal necrosis, followed by fatal septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>For patients with SBS, TED is expected to increase intestinal absorption through epithelial proliferation. When SBS is accompanied by multiple ischemic organ failure, TED therapeutic effects remain unclear as malnutrition-associated infectious diseases are refractory, and many underlying mechanisms can be involved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>TED administration should be deliberately considered for patients with SBS-CIF and multiple organ failure experiencing uncontrolled systemic infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2024.109524","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:48:19Z","timestamp":1710478099000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Teduglutide-induced acute gastric mucosal necrosis in short bowel syndrome with hepatorenal failure: Case report"],"prefix":"10.1097","volume":"117","author":[{"given":"Tohru","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Maejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Fukahori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-65-20260423","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jtcvs.2012.01.042","article-title":"Clinical presentation, management, and short-term outcome of patients with type a acute dissection complicated by mesenteric malperfusion: observations from the international registry of acute aortic dissection","volume":"145","author":"Di Eusanio,","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"R2-65-20260423","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/15385744211017116","article-title":"Malperfusion in acute type a aortic dissection: management strategies","volume":"55","author":"Jaffar-Karballai,","year":"2021","journal-title":"Vasc. Endovascular Surg."},{"key":"R3-65-20260423","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi,","year":"2016","journal-title":"Clin. Nutr."},{"key":"R4-65-20260423","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1016\/j.clnu.2021.07.002","article-title":"ESPEN practical guideline: clinical nutrition in chronic intestinal failure","volume":"40","author":"Cuerda,","year":"2021","journal-title":"Clin. Nutr."},{"key":"R5-65-20260423","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2004.061440","article-title":"Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients","volume":"54","author":"Jeppesen,","year":"2005","journal-title":"Gut"},{"key":"R6-65-20260423","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/gut.2010.218271","article-title":"Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and\/or intravenous fluid requirements in patients with short bowel syndrome","volume":"60","author":"Jeppesen,","year":"2011","journal-title":"Gut"},{"key":"R7-65-20260423","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen,","year":"2012","journal-title":"Gastroenterology"},{"key":"R8-65-20260423","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2012.12.029","article-title":"Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure.","volume":"11","author":"O'Keefe","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"R9-65-20260423","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.69","article-title":"Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome","volume":"7","author":"Schwartz,","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"R10-65-20260423","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0148607116680791","article-title":"Independence from parenteral nutrition and intravenous fluid support during treatment with teduglutide among patients with intestinal failure associated with short bowel syndrome","volume":"41","author":"Iyer,","year":"2017","journal-title":"JPEN. J. Parenter. Enteral Nutr."},{"key":"R11-65-20260423","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ncp.10092","article-title":"Reduction of parenteral nutrition and hydration support and safety with long-term teduglutide treatment in patients with short bowel syndrome-associated intestinal failure: STEPS-3 study","volume":"33","author":"Seidner,","year":"2018","journal-title":"Nutr. Clin. Pract."},{"issue":"5","key":"R12-65-20260423","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus surgical CAse REport (SCARE) guidelines","volume":"109","author":"Sohrabi,","year":"2023","journal-title":"Int. J. Surg."},{"key":"R13-65-20260423","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gut.47.1.112","article-title":"Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse","volume":"47","author":"Benjamin,","year":"2000","journal-title":"Gut"},{"key":"R14-65-20260423","first-page":"E77","article-title":"Intestinal growth-promoting properties of glucagon-like peptide-2 in mice","volume":"273","author":"Tsai,","year":"1997","journal-title":"Am. J. Physiol."},{"key":"R15-65-20260423","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9610(01)00635-3","article-title":"The effect of glucagon-like peptide 2 on intestinal permeability and bacterial translocation in acute necrotizing pancreatitis","volume":"181","author":"Kouris,","year":"2001","journal-title":"Am. J. Surg."},{"key":"R16-65-20260423","doi-asserted-by":"crossref","first-page":"G1249","DOI":"10.1152\/ajpgi.2000.279.6.G1249","article-title":"GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis","volume":"279","author":"Burrin,","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"R17-65-20260423","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/nu8010033","article-title":"GLP-2 prevents intestinal mucosal atrophy and improves tissue antioxidant capacity in a mouse model of total parenteral nutrition","volume":"8","author":"Lei,","year":"2016","journal-title":"Nutrients"},{"key":"R18-65-20260423","doi-asserted-by":"crossref","first-page":"35345","DOI":"10.1074\/jbc.M005510200","article-title":"The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway","volume":"275","author":"Yusta,","year":"2000","journal-title":"J. Biol. Chem."},{"key":"R19-65-20260423","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1210\/me.2004-0196","article-title":"The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1\/2 activation through divergent signaling pathways","volume":"19","author":"Koehler,","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"R20-65-20260423","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/j.semperi.2008.01.002","article-title":"The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis","volume":"32","author":"Chokshi,","year":"2008","journal-title":"Semin. Perinatol."}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261224003055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261224003055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2024.109524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:01:54Z","timestamp":1776978114000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2024.109524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":20,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2024.109524","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"2024-02-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}